Salona Global Medical Device Corporation (SGMD.V)
| Previous Close | 0.4450 |
| Open | 0.4400 |
| Bid | 0.4400 x N/A |
| Ask | 0.4500 x N/A |
| Day's Range | 0.4200 - 0.4500 |
| 52 Week Range | 0.4100 - 0.9500 |
| Volume | |
| Avg. Volume | 87,072 |
| Market Cap | 20.304M |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0980 |
| Earnings Date | Jan 11, 2023 - Jan 16, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 24, 2017 |
| 1y Target Est | N/A |
- GlobeNewswire
Salona Global Announces Third Quarter Results, Posts 211% Year-Over-Year Revenue Growth, 231% in Gross Margin Growth, Improved Gross Margin to 33%; Shifts Focus to Higher Margin Revenue Lines
SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the “Company”) (TSXV:SGMD) today announced highlights for the third fiscal quarter of 2023, ending November 30, 2022. The Company posted 211% year-over-year revenue growth, 231% year-over-year gross margin growth, and improved gross margin as a percentage of revenue by 10% over last quarter to 33%. The Company also provided an update on the progress toward closing the recently anno
- GlobeNewswire
Salona Global to Host Third Quarter 2022 Conference Call on January 17, 2023
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its third quarter 2022 financial results, including details on organic growth for the quarter, deal flow, and acquisition status, on Tuesday, January 17, 2023 at 5:00 pm (Eastern Time) and will issue an earnings press release earlier that morning. Conference call/Webcast Information: Fiscal Third Quarter Earnings
- GlobeNewswire
Salona Global Focuses on US Capital Markets for 2023; Changes Fiscal Year End to December 31, 2022 to Prepare for US Listing; Withdraws Canadian Debenture Offering
SAN DIEGO, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD”, or the “Company”) (TSXV:SGMD) announced today its intention to focus on listing on the Nasdaq Capital Market (“Nasdaq”) in 2023. As a first step, Salona Global has changed its fiscal year end to December 31, 2022 with the aim of preparing for a U.S. listing, and has withdrawn the recently announced debenture offering in Canada. Salona will move forward with the process of closing the r
